Company intelligence
Phacilitate
Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine
About Phacilitate
Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy
Verified activity
Signals from Phacilitate
7 published signals
Presence & Recognition
Phacilitate attended Day 2 of the Advanced Therapies Europe conference in Barcelona.
Reported by Phacilitate
Presence & Recognition
Phacilitate hosted an ATE event with attendees describing ATE in one word.
Reported by Phacilitate
Research & Knowledge
Phacilitate reported that at day 17, about 70% of the circulating T cells in the mouse were CAR positive, resulting in very high transduction efficacy in vivo with a lentiviral vector.
Reported by Phacilitate
Presence & Recognition
Phacilitate attended the ATE26 panel on Europe’s ATMP rulebook reset, featuring experts like Esteve Trias, Jacob G., Rob Allen, and Sean Russell.
Reported by Phacilitate
Presence & Recognition
Phacilitate attended Day 2 of the ATE26 conference where Jacob G., Chief Medical & Scientific Officer at the MHRA Medicines and Healthcare products Regulatory Agency spoke about regulatory principles shaping the future of advanced therapies.
Reported by Phacilitate
Presence & Recognition
Phacilitate participated in Day 1 of Advanced Therapies Europe 2026, featuring the Investment Summit and Women in Advanced Therapies.
Reported by Phacilitate
Presence & Recognition
Phacilitate is exhibiting cocktails by Sunset at the ATE26 event in full swing.
Reported by Phacilitate